Cronos Group Inc. Common Share (CRON) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

Cronos Group Inc. Common Share

NasdaqGM•Healthcare•Drug Manufacturers - Specialty & Generic

$3.19-0.08(-0.02%)Pre-market

Market Cap

$1.25B

P/E

17.9x

P/S

5.3x

P/B

1.2x

Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and tinctures under the Spinach, Lord Jones, Lit, and Peace Naturals brand names. The company is headquartered in Stayner, Canada.

How this company scores

GoodMetricSide Score: 68/100

Strongest: Growth (25/25); weakest: Profitability (13/25).

Profitability13/25

Growth25/25

Balance Sheet & Red Flags15/25

Cash & Earnings Quality15/25

Strengths

Growing revenueRising earningsInterest easily coveredProfit converts from growth

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 17.9x5y range 14.0x – 39.8x

Currently near its 5-quarter median.

P/S · 5.3x5y range 4.1x – 26.7x

Currently near its 20-quarter median.

P/B · 1.2x5y range 0.6x – 1.4x

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

High Risk

Margin Pressure

Red Flag

The company posted negative operating margins in recent quarters — core operations are unprofitable.

Earnings Quality

Red Flag

FCF consistently trails net income (avg -0.7x) — earnings may be inflated by non-cash items or aggressive accounting.

Price & Volume

Market Cap $1.25B

Metrics at a Glance

as of June 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $236.78M
Q. Revenue: $70.60M
TTM EBITDA: $11.86M
TTM Op. Income: $-2.43M
Q. Op. Income: $7.40M
TTM Net Income: $69.98M
Q. Net Income: $32.09M
EPS: $0.09
Shares Out.: $373.61M

$236.78M in TTM revenue grew 36.1% YoY, reaching $70.60M last quarter. TTM EBITDA of $11.86M and TTM operating income of $-2.43M show growth is flowing through to the bottom line. TTM net income of $69.98M means revenue is converting into profit. Across the last 8 quarters, TTM revenue has risen for 7 consecutive quarters — an improving trend.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin: 40.3%
EBITDA Margin: 15.3%
Op. Margin: 10.5%
Net Margin: 45.4%

Op. margin of 10.5% is up 22.5% YoY — cost efficiency is improving. Net margin at 45.4% and gross margin of 40.3% show how much of each revenue dollar survives to profit. Across the last 8 quarters, operating margin has risen for 2 consecutive quarters — an improving trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: 17.9x
P/S Ratio: 5.3x
P/B Ratio: 1.2x

At 17.9x P/E, the stock trades within typical market levels. P/S of 5.3x and P/B of 1.2x provide additional context. Use the growth and margin sections to judge whether the multiple is justified. Across the last 5 quarters, P/E has fallen for 2 consecutive quarters — an improving trend.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $1.18B
Cash: $467.02M
Long-Term Debt: N/A
Book Value: $1.07B
D/E Ratio: N/A
Debt/EBITDA: 0.0

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $24.01M
TTM Free Cash Flow: $49.82M
FCF Margin: 21.0%
FCF / Net Income: 0.7

TTM FCF of $49.82M on $24.01M in operating cash flow. The FCF / Net Income ratio of 0.7x means free cash flow covers net income — earnings are backed by cash. Across the last 8 quarters, free cash flow has risen for 4 consecutive quarters — an improving trend.